March 31, 2021
“At first I was, like, a little nervous because of a fear of shots and needles.”
Last March, Moderna started testing its COVID-19 vaccine on adults.
- The announcement of the younger age group comes earlier than expected – the results from the study for those 12 – 17 have not been released.
- This study focusing on the youngest age group will give recipients two doses, 28 days apart. The doses will have varying amounts, some as high as an adult dose.
- Why It Matters: Dr. Anthony Fauci, National Institute of Allergy and Infectious Diseases (a partner in this study), said he expected the COVID-19 vaccine to be available to high schoolers this fall and elementary school-aged children next year; that timeline was pending trials by drugmakers. Some doctors believe America cannot reach herd immunity against COVID-19 without inoculating children; others disagree.
Here’s the announcement by Moderna.
by Jenna Lee,